Tolerance of fondaparinux in patients with generalized contact dermatitis to heparin.
Schindewolf
M
M
Ludwig
R J
RJ
Wolter
M
M
Himsel
A
A
Zgouras
D
D
Kaufmann
R
R
Boehncke
W-H
WH
Lindhoff-Last
E
E
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000188:drug therapy; D017449:Dermatitis, Allergic Contact / Q000209:etiology* / Q000473:pathology; D004361:Drug Tolerance; D005260:Female; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011134:Polysaccharides / Q000009:adverse effects* / Q000627:therapeutic use; D012867:Skin / Q000473:pathology
D000925:Anticoagulants; D011134:Polysaccharides; D006493:Heparin; D000077425:Fondaparinux